109 results
424B5
PCSA
Processa Pharmaceuticals Inc
28 May 24
Prospectus supplement for primary offering
4:49pm
as our business plans. They are not guarantees of future performance. By their nature, forward-looking statements are subject to risks and uncertainties … in the markets in which we are active, as well as our business plans. They are not guarantees of future performance. By their nature, forward-looking
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
nature of the forward-looking statements include, but are not limited to, those risks and uncertainties related to market and other conditions
8-K
EX-10.1
k8lm1ww6m6x rpwrm0
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
f5s lz673
29 Jan 24
Prospectus supplement with pricing info
4:15pm
8-K
5b0b3ofx 0kvh
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
s97soh0 dkl9hkp
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm